Trials / Completed
CompletedNCT03956459
Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Institut Claudius Regaud · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, monocentric study aiming to evaluate the PET-CT (Positron Emission Tomography - Computed Tomography) scanner performances to detect infra-centimetric lesions in two groups of patients with cancer and of different BMI (Body Mass Index) classes (BMI ≤ 25 and BMI \> 25). For each patient, two consecutive PET-CT scanner will be performed using the "Discovery MI" and "Discovery IQ" PET-CT scanner systems. Virtual lesions will then be created on images obtained. Images will be interpreted by two independent observers. The study participation of each patient will be a maximum of 24 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patients with a cancer for which a FDG-PET scanner must be performed | For each patient, 2 consecutive PET-CT scanners will be performed using 2 different systems of PET-CT scanners: * "Discovery MI" * "Discovery IQ" Only one contrast agent injection (FDG) will be given for both scanners. |
Timeline
- Start date
- 2019-07-25
- Primary completion
- 2021-02-04
- Completion
- 2021-02-04
- First posted
- 2019-05-20
- Last updated
- 2026-04-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03956459. Inclusion in this directory is not an endorsement.